Buccolam
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Buccolam, covering 2018-01-15 to 2024-11-13. Get the full timeline:
Most recent: EMA Authorised: Buccolam (midazolam) — Neuraxpharm Pharmaceuticals S.L.